According to Myriad Genetics's latest financial reports the company's current revenue (TTM) is $0.75 B. In 2022 the company made a revenue of $0.67 B a decrease over the years 2021 revenue that were of $0.69 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.75 B | 11.03% |
2022 | $0.67 B | -1.77% |
2021 | $0.69 B | |
2019 | $0.81 B | 2.04% |
2018 | $0.79 B | 4.32% |
2017 | $0.76 B | 1.76% |
2016 | $0.75 B | 0.56% |
2015 | $0.74 B | 3.01% |
2014 | $0.72 B | -1.66% |
2013 | $0.73 B | 35.17% |
2012 | $0.54 B | 23.08% |
2011 | $0.44 B | 17.5% |
2010 | $0.37 B | 9.15% |
2009 | $0.34 B | -10.56% |
2008 | $0.38 B | 101.73% |
2007 | $0.19 B | 44.48% |
2006 | $0.13 B | 34.53% |
2005 | $98.5 M | 51.13% |
2004 | $65.17 M | 9.34% |
2003 | $59.61 M | -0.15% |
2002 | $59.7 M | 21.7% |
2001 | $49.05 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $40.10 B | 5,225.15% | ๐บ๐ธ USA |
Exact Sciences EXAS | $2.49 B | 231.89% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $2.41 B | 221.19% | ๐บ๐ธ USA |
Biocept
BIOC | -$3.44 M | -100.46% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $2.67 B | 254.66% | ๐บ๐ธ USA |